RNFL thickness after LASIK, LASEK and PRK


Does transient IOP elevation prevent doctors from submitting patients to refractive procedures?

Key Points

Some studies have supported the idea that there is no deleterious effect on retinal nerve fibre layer (RNFL) thickness after LASIK.3,4 Even so, some concern still exists about the possibility that such barotrauma may cause detrimental ganglion cell loss. Taking this into account, there is a trend not to submit glaucoma patients or glaucoma suspects (such patients have increased susceptibility for ganglion cell loss) to refractive procedures characterized by transient IOP elevation (LASIK and epi-LASIK) but instead to choose alternative refractive procedures which do not imply intraocular hypertension (PRK or LASEK).5

Assessing RNFL

There are mainly two kinds of exams used to assess RNFL damage. On one hand, we have the functional exams and, on the other hand, the structural ones. Both types are depicted in Table 1.

Diagnosing RNFL loss by assessing structural changes seems to be more sensitive than their functional damage.6 Subsequently, most published studies have used structural means to assess early RNFL damage. OCT and GDx seem to be more suited to peripapillary RNFL measurements rather than HRT, which is primarily designed for disk morphology evaluation. It is mandatory, however, when using the GDx, to have the variable corneal compensation (VCC) upgrade. The VCC upgrade allows a reliable measurement of RNFL thickness independently from birefringence changes of the cornea subsequent to previous keratorefractive surgery.7,8,9

So, the present study was conducted to evaluate and compare the effect of LASIK and PRK on the peripapillary RNFL using the new TOPCON 3D-OCT.

All eyes had their RNFL thickness measured by OCT preoperatively and postoperatively (1 day, 1 month, 3 months). The measurements were then statistically compared using an unpaired t test. A p value <0.05 was considered significant.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Thomas Bosshard stands at the Oertli Instruments booth at the ESCRS meeting
Eva Kim, MD, speaks about her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.
Trukera Medical rebranding ushers in new era of expansion into cornea market
© 2023 MJH Life Sciences

All rights reserved.